AbbVie's coronavirus response

AbbVie's coronavirus response

As the novel coronavirus (COVID-19) continues to have an increased impact on our communities, we want you to know we are here to help. AbbVie is focused on the health and safety of employees, health care professionals (HCPs) and patients.

We are collaborating with select health authorities and institutions globally on clinical research related to COVID-19. AbbVie is supporting clinical studies and basic research, working closely with Health Canada, European health authorities and the U.S. Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health and Biomedical Advanced Research and Development Authority to coordinate on these efforts.

Learn more about our efforts below: 

We are continuing to closely manage manufacturing and supply chain resources around the world to help ensure our patients continue to receive an uninterrupted supply of their medicines.

We understand your need to know more about the coronavirus. If you are on an AbbVie treatment, please speak with your doctor regarding any questions you may have. Your doctor can provide medical advice to address your individual needs.

AbbVie remains focused on helping support our underserved communities and healthcare systems working to address the impact of the COVID-19 global pandemic. AbbVie’s partners include:

  • Breakfast Club of Canada – who through their COVID-19 Emergency Club Fund is working to achieve the goal that no kid and family should face food insecurity.
  • United Way Centraide Canada – who through their COVID-19 Community Response and Recovery Fund are helping to provide life’s basic needs (food and shelter) and psychological support to many vulnerable populations across Canada.

AbbVie is also pleased to provide additional support to our patient associations, health care organizations and universities, for their COVID-specific activities, via our Grants and Donations program.

AbbVie is also doubling the AbbVie Foundation match for COVID-19-related contributions by employees. Instead of the typical 1:1 match, the AbbVie Foundation will match $2 to every $1 employees donate to a qualified non-profit.

If you are a registered healthcare provider with questions about COVID-19 and AbbVie medications or adverse event reporting, please visit AbbVie’s medical information website, www.abbviemedinfo.com

AbbVie is focused on ensuring the safety of our employees while we continue to make the vital medicines our patients depend on. AbbVie has taken the following steps to protect health at work for our employees:

  • A significant number of our employees who have jobs that can be done remotely are now working from home.
  • For those people who need to be at an AbbVie facility to do their job, we’ve taken aggressive steps to limit exposure risk and keep our worksites as safe as possible.
  • We support social distancing at all facilities where possible and encourage all employees to practice recommended safety measures.
  • Enacted strict travel restrictions in accordance with government guidance. 

We will continue to closely monitor this evolving situation during this unprecedented global health crisis.

For assistance accessing your medication or if you have any questions, please contact AbbVie Customer Relations or AbbVie Medical Information at

1-888-704-8271 / 514-906-9771.

For AbbVie Care members, please refer to AbbVie Care’s Web site.

For the latest information about COVID-19, visit the following Web sites:
Government of Canada
World Health Organization
Centers for Disease Control and Prevention